We describe here the isolation of a full-length cDNA encoding a Xenopus orthologue of the mammalian EphA2 receptor tyrosine kinase and investigate its role in cranial neural crest migration. We show that the primary sites of Xenopus EphA2 expression are rhombomere 4 of the developing hindbrain, migratory cranial neural crest cells and mesoderm of the visceral arches. To interfere with EphA2 and related receptors during cranial neural crest migration, we took a dominant negative approach. Overexpression of kinase-deficient EphA2 receptor variants led to abnormal migration of cranial neural crest cells. Neural crest cells of the third arch were found to mismigrate posteriorly, resulting in the failure of third and fourth arch neural crest to separate into distinct streams. These defects could be rescued by expression of full-length EphA2 receptors. A comparison of the expression domains of EphA2-binding proteins mapped by receptor affinity probe (RAP) in situ staining with those for EphA2 receptors revealed co-expression of ligands and receptors in the visceral arch mesenchyme. Taken together, these results suggest that EphA receptors may mediate attractive or adhesive signals during migration of cranial neural crest cells.
Introduction
The cranial neural crest plays a central role in determining the shape of the developing vertebrate head by contributing to skeletal and muscular components (Le Douarin, 1982; Noden, 1991; Köntges and Lumsden, 1996) . Cranial neural crest cells originate at the lateral edges of the neural plate, detach during neurulation at the level of the midbrain and from discrete segmental levels of the hindbrain, the rhombomeres (r), and migrate laterally into the adjacent arches. In the chicken embryo, neural crest cells derived from r1 and r2, contribute to the first arch and the trigeminal ganglion, neural crest from r4 populate the second arch and the facial and vestibuloacoustic ganglia, and neural crest from r6 and r7 migrate into the third and fourth arches and the superior ganglion of the IXth nerve (Lumsden et al., 1991; Birgbauer et al., 1995; Köntges and Lumsden, 1996) . The preferential elimination of cells by apoptosis observed in r3 and r5 (Graham et al., 1993) suggested that these rhombomeres may not contribute neural crest cells to the arches. Recent in vivo studies have however demonstrated that the majority of neural crest emigrate from the neural tube prior to the period of apoptosis. Neural crest cells originating from r3 and r5 provide distinct populations of cells that migrate anteriorly and posteriorly towards the first and second arch or second and third arch, respectively (Sechrist et al., 1993; Birgbauer et al., 1995) . It therefore appears that guided migration rather than selective apoptosis is responsible for establishing streams of neural crest cells.
Migration of cranial neural crest cells occurs in discrete (i.e. non-mixing) streams along stereotypic pathways to their target destinations, the pharyngeal pouches (Sadaghiani and Thiébaud, 1987; Köntges and Lumsden, 1996) . Little is known about the molecular nature of the signals that guide neural crest cells. A number of molecules, such as extracellular matrix components and their receptors, have been implicated as candidates, but unequivocal in vivo evidence is still lacking (Bronner-Fraser, 1993; Perris, 1997) . For example, targeted mutagenesis of integrin family members has so far only revealed a role for the a5 integrin subunit in the survival of cranial neural crest cells (Fässler et al., 1996; Goh et al., 1997) . Despite the lack of direct evidence for extracellular matrix molecules in actively guiding neural crest cells, these molecules nevertheless provide permissive substrates for migration. Based on transient expression in migrating neural crest cells, members of the Eph receptor family have also been postulated as candidates for regulating neural crest cell migration (Ganju et al., 1994; Brändli and Kirschner, 1995) . Recent functional studies have now indeed provided first evidence for such a role (Krull et al., 1997; Smith et al., 1997; Wang and Anderson, 1997) .
The Eph receptor family consists currently of 14 structurally related receptor tyrosine kinases (Flanagan and Vanderhaeghen, 1998; Zhou, 1998) . They can be subdivided on the basis of sequence homologies and ligand binding preferences into two subclasses, the EphA and EphB receptors Eph Nomenclature Committee, 1997) . Ephrins, the ligands of Eph receptors, comprise two subclasses of eight related proteins. The ephrin-A subclass is anchored in the plasma membrane by glycosylphosphatidylinositol (GPI) linkage and interacts with EphA receptors, while the ephrin-B subclass are transmembrane proteins, which bind to EphB receptors. The only exception to this rule is EphA4 which binds to ephrin-A as well as to some ephrin-B ligands Gale et al., 1996) . Ephrins only activate receptors when membrane bound or clustered artificially (Davis et al., 1994; Stein et al., 1998b) indicating that Eph receptors mediate cell contact-dependent signaling. Molecular and genetic evidence also suggests that ephrin-B ligands are direct targets of tyrosine kinases and may be capable of transmitting an intracellular signal Holland et al., 1996) . Ephrins within each subclass are promiscuous in their binding to the complementary subgroup of Eph receptors . The composite developmental expression pattern of each ligand and receptor subclass suggests a molecular role in defining boundaries during embryogenesis Gale et al., 1996) .
The importance of the Eph receptor family in regulating cell migration was first noticed in the developing central nervous system where they have been implicated in the control of axonal pathfinding and targeting within the retinotectal system (Flanagan and Vanderhaeghen, 1998; Holland et al., 1998) . Using in vitro stripe assays, Drescher et al. (1995) purified ephrin-A5 and established its properties as a repulsive guidance protein for growth cones of retinal ganglion cells. A role for Eph receptors and their ligands as mediators of repulsive guidance signals was also supported by the discovery of complementary expression gradients of ephrin-A2 across the tectum and of its receptor EphA3 in the retinal neurons (Cheng and Flanagan, 1994; . Misexpression of ephrin-A2 in the chicken tectum using a retroviral expression system leads to errors in the targeting of retinal ganglion axons since they avoid areas of ectopic ephrin-A2 expression (Nakamoto et al., 1996) . The ability to act as repulsive guidance molecules on axonal outgrowth is not restricted to ephrin-A ligands. Ephrin-B1 and ephrin-B2 induce the collapse of growth cones of spinal motor neurons in vitro, and probably represent some of the crucial repulsive cues in the posterior half of the somites (Wang and Anderson, 1997) . Together, these findings suggest that Eph receptors and their ligands may act in concert to guide axonal outgrowth. This notion is further supported by analysis of mice deficient in either EphA8, EphB2, EphB3 or ephrin-A5 which all display highly specific defects in axonal projections Orioli et al., 1996; Park et al., 1997; Frisén et al., 1998) .
Axonal outgrowth and migration of neural crest cells have in common that both processes require migration over long distances along specific pathways to reach the final target sites. It is therefore conceivable that Eph receptors and ephrins not only guide outgrowing axons in the nervous system, but also play a role in the migration of neural crest cells. This is indeed supported by recent experimental evidence. In several independent assays, ephrin-B1 and ephrin-B2 ligands were shown to exhibit repulsion activity on outgrowing trunk neural crest cells in vitro (Wang and Anderson, 1997) . Interference with Eph receptor signaling by ectopic expression of either ephrin-B2 ligands or dominant negative forms of Eph receptors leads to defects in the migration of cranial neural crest cells in Xenopus (Smith et al., 1997) . Furthermore, in vitro studies have shown that trunk neural crest cells which express EphB3 receptors are disturbed in their migratory behavior upon ectopic exposure to ephrin-B1 ligands (Krull et al., 1997) . These results indicate that the underlying mechanisms for Labrador et al. (1997) . The two fibronectin type III (FN III) domains have been defined based on high sequence conservation with other FN III domains (O'Bryan et al., 1991) . The predicted transmembrane domain is double underlined. The tyrosine kinase domain as defined by Hanks et al. (1988) is contained within the arrows. The cytoplasmic tyrosine residues that were found to be conserved among all vertebrate EphA2 proteins are highlighted by a black dot. White arrows above the nucleotide sequence indicate the C-termini of the truncated EphA2 proteins, scEphA2 and tmEphA2, used in this study.
guidance of axons and migrating neural crest cells may be similar.
It is currently not known if ephrin-A ligands and their receptors play equal roles in neural crest migration. Visceral arch expression of several members of the EphA receptor family as well as of the ephrin-A ligands has been reported for mouse, chicken and Xenopus embryos. These include EphA2, EphA3, EphA4 and EphA7 receptors (Nieto et al., 1992; Becker et al., 1994; Winning and Sargent, 1994; Brändli and Kirschner, 1995; Ellis et al., 1995; Xu et al., 1995) and ephrin-A4 and -A5 . However, mice deficient in single EphA receptor genes do not display any obvious defects in craniofacial structures, indicating possible functional compensation by the remaining EphA family members (Chen et al., 1996; Park et al., 1997) . We therefore decided to address the question whether EphA receptors are required for cranial neural crest migration by overexpressing dominant negative forms of the EphA receptor, EphA2. We demonstrate here that EphA receptor signaling is required for normal migration of neural crest cells by controlling the proper segregation of third and fourth arch neural crest streams.
Results

Cloning and sequence analysis of a cDNA encoding Xenopus EphA2
A PCR-based search for tyrosine kinase receptors expressed during early Xenopus embryogenesis yielded two pseudoallelic partial cDNAs, G42 and G50, encoding novel kinase domain segments that exhibited extensive homology to mammalian EphA2 (Brändli and Kirschner, 1995) . We screened at high stringency a Xenopus cDNA library to isolate full-length cDNAs (for details, see Section 4). One clone, HD.C5, proved to include a complete open reading frame encoding a putative primary translation product of 977 amino acids. The nucleotide and deduced amino acid sequence is shown in Fig. 1 . The predicted N-terminus carries the characteristic features of cleavable signal peptides (von Heinje, 1985) . The deduced sequence contains all the sequence homologies and structural domains characteristic of Eph family receptors (Fig. 1) . Within the open reading frame of HD.C5, bases 2417-2687 were found to be identical with the nucleotide sequence of G42. While our functional studies were in progress, a partial Xenopus Ephrelated cDNA, named XE10, was reported (Weinstein et al., 1996) . Sequence comparison revealed that XE10 is identical to bases 807-1026 of HD.C5.
When compared to other members of the Eph receptor family, the deduced amino acid sequence of HD.C5 shared 70% identity to human and mouse EphA2 (Lindberg and Hunter, 1990; Ganju et al., 1994) . In contrast, the next most closely related Eph family member, chicken EphA5 (Siever and Verderame, 1994) , shares an amino acid identity of 51%. A comparison of N-terminal globular domains which are responsible for subclass-specific ligand binding (Labrador et al., 1997) revealed identities of 78% and 76% to mouse and human EphA2, respectively. Identities of HD.C5 to other EphA family members ranged from 54% to 56%, and are below 50% for EphB receptors. The close identity between Xenopus HD.C5 and mammalian EphA2 proteins together with the similarities in their embryonic expression patterns (see below), suggest that they represent the amphibian and mammalian orthologues of the same progenitor gene. We will therefore refer to HD.C5 as EphA2.
Expression of the EphA2 gene during Xenopus embryogenesis
We performed Northern blot analysis of poly(A) + RNA isolated from various developmental stages to elucidate the temporal regulation of EphA2 transcription during Xenopus embryogenesis ( Fig. 2A) . Examination of the blot revealed that the EphA2 gene was expressed as a single 4.8 kb transcript throughout the embryonic stages tested. EphA2 mRNA expression levels peaked after completion of neurulation (stage 19). Based on the presence of a single transcript, we conclude that EphA2 transcripts, unlike those of other Eph family members (Zisch and Pasquale, 1997) , appear not to be subjected to alternative RNA splicing.
EphA2 transcripts are localized to rhombomere 4 and the visceral arches
The spatial patterns of EphA2 gene expression were determined by in situ hybridization (Fig. 3) . At late gastrula stage (stage 12; Fig. 3A ), EphA2 expression was confined to the ectodermal layer of the posterior half of the embryo. High levels of posterior EphA2 expression persisted throughout the stages analyzed (Fig. 3A-E) . Transverse sections of stage 26 embryos at the level of the tailbud indicated that EphA2 gene expression in this posterior expression domain was associated with the epidermal ectoderm and the notochord (Fig. 3F) . By neural plate stage (stage 13; Fig. 3A ), EphA2 transcripts appeared in two narrow stripes in the neural plate. One stripe was located at the anterior edge of the neural plate consistent with the expression seen later in the forebrain, while the other, more posterior stripe was in the region of the future hindbrain. At stage 23 (Fig. 3C) , while lateral migration of cranial neural crest cells into the visceral arches is in progress, EphA2 transcripts were found associated with a single rhombomere (r) in the hindbrain and with the visceral arch immediately anterior to the otic vesicle. To map the location of EphA2 expression in the hindbrain, EphA2 and Krox-20 expression patterns were compared. Krox-20 is expressed in r3 and r5 as well as in migratory neural crest cells of the third arch (Bradley et al., 1992) . At stage 23, EphA2 is expressed in the second arch and faintly in r4 (Fig. 3H) . In tailbud embryos at stage 27, expression of EphA2 was more pronounced in r4 (Fig. 3I ). In addition, EphA2 transcripts were also detected in the ventral portions of the third and fourth arch. Examination of transverse sections of stage 26 embryos revealed that EphA2 expression in r4 was restricted to the dorsal hindbrain (Fig. 3G ). Closer inspection of stage 27 embryos and of transverse sections of slightly younger stage 26 embryos revealed EphA2 transcripts associated with cells in the vicinity of the otic vesicle ( Fig. 3D,G) . The dorsoanterior position of these cells is consistent with EphA2 expression in neurogenic neural crest cells of the facial (VIIth) cranial ganglion which projects a nerve to the second arch (Noden, 1991; HemmatiBrivanlou et al., 1992) . By stage 30 (Fig. 3E ), EphA2 transcripts had been strongly downregulated in most tissues with exception of the tailbud.
Overlapping expression domains of EphA2 receptors and their ligands in the visceral arches
We carried out in situ hybridizations on horizontal sections of tailbud embryos to determine which cellular layers of the visceral arches express EphA2 transcripts. EphA2 expression was associated with all tissues of the second visceral arch which includes the epidermal layer, the mesenchyme, and the pharyngeal endoderm ( Fig. 4G ). Uniform staining of the visceral arch mesenchyme indicates that both, neural crest and mesoderm, are expressing EphA2 transcripts. A similar situation was seen in the neighboring third visceral arch ( Fig. 4G ; data not shown).
To complement these observations, we examined the distribution of EphA2 ligands in the visceral arches. In vitro studies have demonstrated that all ephrin-A ligands tested to date will bind with high affinity to EphA2 receptors Gale and Yancopoulos, 1997) . We therefore used the RAP (receptor affinity probe or receptor alkaline phosphatase) in situ staining method (Cheng and Flanagan, 1994) to identify potential expression sites of EphA2 ligand proteins. We constructed and produced recombinantly a soluble fusion protein, EphA2-AP, by fusing the extracellular domain of EphA2 to the human placental alkaline phosphatase (AP) protein (Fig. 5 ; for details, see also Section 4). As a control for specific binding of the EphA2-AP protein, embryos were incubated with unfused AP, which showed no staining (Fig. 4A) . Examination of whole embryos revealed widespread EphA2-AP staining in the head, the region of the visceral arches, and with dorsal aspects of the trunk (Fig. 4B ). Ventral parts of the embryo were devoid of staining. In horizontal sections, we were able to detect specific staining in the eye vesicles, the fore-and midbrain, and developing somites (Fig. 4E ). Somitic staining was restricted to the dermatome and the intersomitic borders ( Fig. 4E ; data not shown). No staining was observed in the head mesenchyme, endodermal derivatives and in unsegmented somitogenic mesoderm.
RAP in situ staining indicated that EphA2-binding proteins were associated with all four arches in a staining pattern reminiscent to that of the cranial neural crest marker twist (compare Fig. 4C with Fig. 4D ). We performed horizontal sections to determine which tissues of the visceral arches were positive for EphA2-AP staining. Staining was limited to the epidermal layer and the mesenchyme (neural crest and mesoderm) of the visceral arches (Fig. 4F ). Taken together, these results indicate that the expression domains of the EphA2 receptor and its potential ligands overlap within the visceral arch mesenchyme. No staining was is seen in unsegmented somitogenic mesoderm (sm) and in head mesenchyme (hm). (F) Close-up view of a 75-mm horizontal section through the embryo shown in (B). The plain of section was below the eye vesicle. Staining was detected in the forebrain (white arrowhead), and in the epidermal layer (black arrowhead) and mesenchyme (black arrow) of the visceral arches. Note the absence of staining in the pharyngeal endoderm (white arrow). (G) 75-mm horizontal section through a stage 27 embryo hybridized with a EphA2 probe. The plain of section shown was below the eye vesicle as in (F). EphA2 transcripts are detected in the epidermal (black arrowhead), mesenchymal (black arrow) and endodermal (white arrow) layers of the second visceral arch. Staining in the third visceral arch is indicated with a white arrowhead.
EphA2 signaling is not necessary for neural crest cell migration in the second visceral arch
Eph receptors are activated by ligand-induced receptor oligomerization which triggers phosphorylation of the catalytic domains and subsequently initiates downstream signaling pathways (Gale and Yancopoulos, 1997; Stein et al., 1998b) . Activation of Eph receptors can be disrupted by overexpression of mutant Eph receptor variants favoring the formation of inactive heterooligomers between normal and mutant receptors (Xu et al., 1995; Smith et al., 1997; Stein et al., 1998a,b) . We therefore chose a dominant negative approach to elucidate the role of EphA2 in the hindbrain segmentation and cranial neural crest cell migration. A membrane-anchored EphA2 mutant, tmEphA2 (Fig. 5B) , lacking the tyrosine kinase domain was designed analogous to previous truncated Eph receptor mutants used in the Xenopus embryo (Xu et al., 1995; Smith et al., 1997) . Synthetic RNA encoding tmEphA2 was injected into one blastomere of a two-cell stage embryo, while the uninjected blastomere served as a control. RNA encoding nuclear bgalactosidase was usually co-injected with tmEphA2 in order to trace the distribution of injected RNAs. Injected embryos were allowed to develop to stage 23. Since the development of injected embryos occurred normally without any externally visible defects, embryos were analyzed by in situ hybridization for possible defects in tissues expressing endogenous EphA2. Inspection of stained embryos failed to reveal obvious defects in neural crest and mesoderm of the second arch (three independent experiments with a total of 205 inspected embryos; Fig. 6A,B) . Overexpression of tmEphA2 did also not affect the segmental restriction of EphA2-expressing cells to r4 ( Fig. 6A,B ; data not shown). Horizontal sections of stained embryos did also appeared normal (data not shown). Based on these results, together with data obtained with other second arch neural crest markers (see below), we conclude that EphA2 signaling is dispensable for neural crest and mesodermal cells of the second arch.
Overexpression of truncated EphA2 receptors results in abnormal migration of third arch neural crest cells
We asked next whether overexpression of tmEphA2 might have an effect on cells of the more posterior arches, which had been found to express EphA2, however at lower levels (Figs. 3I and 4G) . To address this question, we used initially EphA4 as a marker for r3 and r5, and for neural crest and mesoderm of the third arch (Winning and Sargent, 1994; Xu et al., 1995) . Analysis of stage 23 embryos showed that tmEphA2 overexpression caused third arch neural crest cells to occupy a wider area as illustrated by a shift of the posterior boundary of EphA4-expressing neural crest cells towards the pronephric anlage (Fig. 6C,D) . We extended our analysis by including additional molecular markers and by investigating later stages. Inspection of injected stages 25-26 embryos revealed that the leading edge of EphA4-expressing neural crest cells in the third arch was now occupying ventral positions similar to the controls (Fig.  7A,B) . This indicates that neural crest migration as such was not impaired by tmEphA2 overexpression. We observed however that the territory covered by EphA4-positive cells was expanded with the posterior boundary shifting towards the pronephric anlage (Fig. 7A,B) . This phenotype was observed with a high incidence (73%, n = 77; Table  1A ), and did not occur when embryos were injected with full-length EphA2 RNA (Table 1A) . Analysis of embryos using Krox-20 expression as an alternative marker of third arch neural crest (Bradley et al., 1992) revealed a similar picture with Krox-20 expressing cells occupying a wider area and spreading to adjacent posterior territories (Fig.  7C,D) . Next, we injected embryos with varying amounts of tmEphA2 RNA to test whether the observed effects were dose-dependent. We found that injection of 1.2 ng RNA, the highest amount tested, caused a third arch neural crest phenotype in over 90% of the embryos (Table 1A) . Reducing the amount of injected RNA to 0.2 ng still allowed for an incidence in the range of 50%. We also found that coinjection of an excess of full-length EphA2 over tmEphA2 RNA led to a dramatic suppression of the neural crest phenotype with the incidence dropping from 71% to 24% (Table 1A ). These data indicate that normal migration of third arch neural crest cells can be restored by the catalytic domain of EphA2. While mismigration of third arch neural crest cells was readily apparent in embryos overexpressing tmEphA2, abnormalities in r3, r4 and r5 as determined by marker gene expression could not be detected (Figs. 6C,D; 7A-D; data not shown).
Overexpression of tmEphA2 prevents the separation of third and fourth arch neural crest cells
We have observed so far that tmEphA2 overexpression affects migration of neural crest cells of the third arch, while those of the second arch remain unobstructed. To examine the possible effects of tmEphA2 overexpression on cells of the first and fourth arch, we analyzed injected embryos for AP-2 and twist expression, two molecular markers that are expressed in all cranial neural crest cells (Hopwood et al., 1989; Winning et al., 1991; Schuh et al., 1993) . Neural crest cells of the first and second arch remain separate streams of cells during the entire migration period. A third group, however, representing cells of the third and fourth arch migrate in Xenopus embryos initially together (Sadaghiani and Thiébaud, 1987) . Analysis of embryos overexpressing tmEphA2 for AP-2 expressing cells revealed that migration of neural crest cells occurred normally around the eye and into the first arch (Fig. 7E,F) . Equally and consistent with earlier observations (see Fig. 6A,B) , neural crest cells of the second arch were also undisturbed. Examination of the third more posterior group of cells revealed however an abnormal behavior. These cells destined to populate the third and fourth arch failed to separate into distinct streams around stages 24-25 (Fig. 7E,F) . This abnormal behavior was also observed after staining for twist expression (Fig. 7G,H) . The incidence of the phenotype could be increased by injecting more tmEphA2 RNA. On the other hand, embryos were rescued by co-injecting full-length EphA2 (Table 1A) . It is likely that the observed lack of neural crest stream separation is at least in part caused by the abnormal posterior migration of third arch neural crest cells.
Mutant EphA2 receptors require the entire extracellular domain to perturb neural crest migration in a dominant negative manner
The extracellular domain of Eph receptors consists of a N-terminal globular domain harboring the principal ligandbinding activity followed by a cysteine-rich region and two FN III domains (Labrador et al., 1997) . It is therefore conceivable that overexpression of secreted forms of the extracellular domain of EphA2 may inhibit neural crest migration by competing for ligand binding. We constructed a series of soluble deletion mutants of the EphA2 extracellular domain (Fig. 5C-F) and tested their ability to perturb migration of neural crest cells in vivo. scEphA2 was constructed by removing the membrane anchor present in tmEphA2, while leaving the entire extracellular domain intact (Figs. 1 and 5C ). In overexpression experiments, migration of first and second arch neural crest cells were unaffected as demonstrated by analysis of molecular markers such as twist (Fig. 8C,D) , AP-2 and EphA2 (data not shown). Examination of third arch neural crest cells expressing EphA4 (Fig. 8A,B) and Krox-20 (not shown) revealed aberrant migratory behavior resembling the phenotypes observed in tmEphA2 overexpressing embryos (compare with Fig. 6A,B) . Further, the separation of third and fourth arch neural crest cells was found to be suppressed in scEphA2-expressing embryos (twist: Fig. 8C,D ; AP-2: data not shown). The effects were observed with incidences ranging from 50% to 80% and were found to be specific, since we were able to rescue the normal phenotype by co-expression of scEphA2 with an excess of full-length EphA2 (Table 1B) . In contrast, overexpression of mutant EphA2 proteins encompassing further C-terminal deletions of the extracellular domain (Fig. 5D-F) were significantly less effective. They produced neural crest migration defect in less than 10% of the injected embryos (data not shown). These results indicate that mutant forms of EphA2 must contain the complete extracellular domain of EphA2 in order to act as potent dominant negative inhibitors. a n is in parentheses where n is the total number of embryos analyzed. n.d., not determined. One blastomere per embryo at the two-cell stage was injected with the RNAs indicated. Embryos were allowed to develop to stages 24-26, fixed and processed for in situ hybridization. The injected sides of embryos were scored for abnormalities in neural crest cell migration. A minimum of two independent experiments was carried out for every injection.
Discussion
The molecular mechanisms controlling correct segregation and pathfinding of neural crest cells are poorly understood, however recent evidence suggests that Eph receptors and their ligands play a central role in these processes (Krull et al., 1997; Smith et al., 1997; Wang and Anderson, 1997) . We report here the cloning of the Xenopus EphA2 orthologue and show that its expression is associated with cranial neural crest cells. Furthermore, we were able to demonstrate by overexpressing dominant negative EphA2 receptor mutants a specific requirement for EphA signaling in the process leading to the segregation of cranial neural crest cells of the third and fourth arch.
Cloning and embryonic expression of the Xenopus EphA2 orthologue
We had previously reported the cloning of two partial pseudoallelic cDNAs, G42 and G50, encoding polypeptides with high homology to the EphA2 receptor (Brändli and Kirschner, 1995) . Cloning of the corresponding full-length cDNA and sequence analysis of the predicted polypeptide indicated closest similarity to mammalian EphA2. Further compelling evidence for having cloned the Xenopus orthologue of mammalian EphA2 was provided by comparison of the developmental expression patterns. The conservation of expression sites between mouse EphA2 (Becker et al., 1994; Ganju et al., 1994; Ruiz and Robertson, 1994) and Xenopus EphA2 includes the ectoderm and the developing notochord of the posterior part of the embryo, the prospective rhombomere 4, and the visceral arches. The only difference relates to the expression in the embryonic forebrain, where EphA2 transcripts could not be detected in the mouse.
Expression of Eph receptors and ligands in the visceral arches
Several vertebrate EphA receptors have been shown to be expressed either in single or multiple visceral arches. These include EphA7 in the first arch (Ellis et al., 1995) , EphA3 in the first and second arch (Cheng and Flanagan, 1994) , and EphA4 in the third arch (Nieto et al., 1992; Winning and Sargent, 1994; Xu et al., 1995) . We found for the Xenopus EphA2 gene that its expression occurs transiently at high levels in cells of the visceral arches and ceases once neural crest cell migration is completed. EphA2 transcripts appeared initially in the second arch, later also in the more posterior arches. Sectioning revealed that expression of EphA2 is found in all layers of the second visceral arch, which include the ectoderm, the neural crest, the mesoderm and the pharyngeal endoderm. The observed regulation of EphA2 expression in the visceral arches of Xenopus embryos is essentially identical to the situation found in the mouse embryo (Ganju et al., 1994; Ruiz and Robertson, 1994) . Expression of Eph receptors in multiple adjacent layers of the visceral arches does not seem to be unusual, since a similar observation was reported recently for EphA4 (Winning and Sargent, 1994; Smith et al., 1997) . The expression pattern of potential EphA2 ligands in the visceral arches was established using the RAP in situ staining method. EphA2-binding proteins were detected in the ectodermal layer, the neural crest and the mesoderm of all visceral arches. The staining pattern could result either from interaction with a single or multiple ephrin-A class ligands. We tend to favor the latter possibility given the promiscuity of ligand binding to EphA2 receptors. Furthermore, an extensive in situ hybridization study has recently revealed that murine ephrin-A4 and -A5 transcripts are associated with the ectodermal component of all visceral arches . The ectodermal expression of mouse ephrin-A ligands is consistent with our observations using the EphA2 affinity probe. However, we also detected EphA2 ligand expression in the mesenchyme of the visceral arches indicating that other, yet to be characterized, ephrin-A ligands are likely to be expressed in the visceral arch mesenchyme. Comparison of receptor and ligand expression reveals that EphA2 receptors and their ligands are coexpressed in the neural crest and the mesoderm of the visceral arches.
The expression in the visceral arches is not limited to the EphA receptors and ligands of the class A. Transcripts for Xenopus EphB1 are detected in neural crest, mesoderm and endoderm of the third and more posterior arches (Jones et al., 1995; Scales et al., 1995; Smith et al., 1997) , and EphB3 receptors have been reported in the first and second arch (Becker et al., 1994) . In Xenopus, ephrin-B2 is expressed in second arch neural crest and mesoderm (Smith et al., 1997) , while in the mouse embryo, ephrin-B1 and -B2 are found in the mesenchyme of several visceral arches Bouillet et al., 1995; Flenniken et al., 1996) . Although the data currently available is incomplete, it appears that the visceral arch mesenchyme not only coexpresses EphA receptors and ligands, but also EphB receptors and their ligands.
Taken together, gene expression in the visceral arches is characterized by the expression of multiple Eph receptor and ligand family members. Further, the relationship between the expression patterns of Eph receptors and ligands in the visceral arches is characterized by overlapping rather than complementary expression domains with the mesoderm and neural crest expressing both receptors and ligands. This is in contrast to the situation found in the embryonic trunk where the reciprocal compartmentalization of Eph family binding partners underlies the segmental migration of neural crest cells (Krull et al., 1997; Wang and Anderson, 1997) . These differences suggest that Eph receptor signaling might have different roles in the regulation of cranial and trunk neural crest migration.
Inactivation of Eph receptor function by ectopic expression of dominant negative mutants
The EphA2 receptor was initially thought to play a role in pattern formation during gastrulation, hindbrain segmentation and limb development (Ganju et al., 1994; Ruiz and Robertson, 1994) . However, recently it was shown that mice deficient for EphA2 do not exhibit any discernible phenotypes (Chen et al., 1996) , which suggests that other Eph receptor family members can functionally compensate for the loss of the EphA2 receptor gene. The considerable overlap of Eph receptor expression in the visceral arches in combination with the reported promiscuity of receptorligand interactions are in support of this interpretation. Furthermore, mice deficient for EphB2 as well as EphB3 show more severe defects than the single mutants .
The use of dominant negative mutants provides the possibility of simultaneous inactivation of multiple related receptors and thus may reveal novel biological roles. Indeed, in contrast to the situation in EphA2-deficient mice, our overexpression experiments using dominant negative mutants yielded a specific cranial neural crest phenotype which could by rescued by full-length EphA2 receptors. The neural crest phenotype was only seen at high incidences when tmEphA2 and scEphA2, two mutants of EphA2 that contain the entire extracellular domain, were overexpressed. Soluble shorter variants of EphA2, while still retaining the ligand binding globular domain, are not able to efficiently elicit a neural crest migration phenotype in vivo. The reduced potency of these reagents might be caused by an inability to oligomerize or by reduced stability in the embryo. Interestingly, we found no significant differences in the phenotypes or in the proportion of embryos affected after overexpression of either tmEphA2 or scEphA2, suggesting that they block the activity of endogenous EphA2 by the same mechanism(s). In principle, dominant negative mutants could disrupt Eph signaling by hetero-oligomerization with endogenous Eph receptors and/ or by sequestering ligands.
Distinct roles for Eph receptors in cranial neural crest cell migration?
Cranial neural crest cells migrate from the dorsal hindbrain in separate streams along stereotypic pathways into the visceral arches. In Xenopus, cranial neural crest of the third and fourth arch start migration initially adjacent to each other, but segregate later into distinct streams (Sadaghiani and Thiébaud, 1987) . Based on morphological studies, there are no physical barriers that would keep neural crest streams apart until they are separated by entering the pharyngeal pouches (Smith et al., 1997) . Other mechanisms must therefore exist to prevent mixing of cranial neural crest cells during migration. Functional studies involving EphA4 and EphB1 receptors as well as ephrin-B2 suggest that Eph signaling regulates migration of cranial neural crest cells (Smith et al., 1997) . In the present study, we have been focusing our efforts exclusively on dissecting the role of EphA2 receptors in cranial neural crest migration. Similar to Smith et al. (1997) , we found that mismigration of neural crest cells was limited to cells of the third and possibly fourth arch. While these arches were shown to express EphA2, highest levels of EphA2 transcripts are associated with the second arch. The lack of a discernible phenotype in the second arch might indicate that inactivation of endogenously expressed EphA2 is not sufficient and/or compensation might occur through receptors of the EphB class (e.g. EphB3).
In embryos overexpressing truncated EphA2 receptors, we observed that the separation of third and fourth arch neural crest into distinct streams was suppressed. On the cellular level, the observed phenotype could be caused by mismigration of both third and fourth arch neural crest cells or by abnormal behavior of only one of the two. Using Krox-20 and EphA4 as markers of third arch neural crest cells, we consistently observed that the stream of third arch neural crest cells was abnormally broader. Since we did not observe ectopic cells in more anterior locations, the broadening seems to be primarily caused by third arch neural crest cells occupying additional territories to the posterior. Mismigration of fourth arch neural crest cells might also contribute to the observed phenotype. In the absence of fourth arch-specific molecular markers, we are currently unable to determine whether this is the case and whether intermingling of third and fourth arch neural crest cells actually occurs.
Mismigration of third arch neural crest cells in embryos overexpressing truncated EphA4, EphB1 or mixtures of both receptors occurs in anterior as well as posterior direction (Smith et al., 1997) . On the other hand, we observed that overexpression of dominant negative EphA2 receptors causes third arch neural crest cells to invade only posteriorly into adjacent fourth arch territory. Together, these results provide evidence that Eph receptors may differentially regulate third arch neural crest migration. The neural crest defect caused by overexpression of truncated EphA2 is unlikely to be caused by disruption of EphA2 signaling alone, since mice deficient for EphA2 do not exhibit defects in the neural crest (Chen et al., 1996) . Inhibition of other EphA receptors must therefore occur, and EphA4 may represent a possible candidate. Since overexpression of truncated EphA4 causes also anterior mismigration defects, the inhibition of EphA4 by truncated EphA2 receptors must however be incomplete. The variations in the phenotypes might therefore be attributed to differences in receptor oligomerization and/or ligand interaction that influence in a subtle way the guidance of migrating neural crest cells in vivo.
Eph receptors in cranial neural crest migration: repulsive or attractive signaling?
Mismigration of cranial neural crest cells can be induced in the Xenopus embryo by ectopic expression of ephrin-B2 or dominant negative versions of EphA2, EphA4, and EphB1. What type of signal does activation of Eph receptors provide to migrating cranial neural crest cells? In the nervous system, Eph signaling has been implicated in mediating repulsive cues for axon growth and topographic mapping (Flanagan and Vanderhaeghen, 1998; Holland et al., 1998) . Repulsive activities exerted by ephrins have also been reported to act on neural crest cells. Migrating neural crest cells in the trunk are repelled by posterior somite halves, and therefore migration occurs selectively through the anterior half of each somite during embryogenesis (Bronner-Fraser and Stern, 1991) . In vivo blocking experiments and in vitro cell migration assays indicate that ephrin-B1 and ephrin-B2 restrict migration to the anterior half of each somite by mediating a repulsive signal (Krull et al., 1997; Wang and Anderson, 1997) . On the other hand, ephrin-A1 can promote angiogenesis in vivo as well as endothelial cell chemotaxis (Pandey et al., 1995) , and very recently ephrin-B1 has been shown to promote capillary-like assembly of renal endothelial cells in vitro (Stein et al., 1998b) . These latter data suggest that, at least for endothelial cells, Eph receptors and their ligands may mediate attractive or adhesive cues to provide stable cell-cell contacts. Cell clustering observed in mixing experiments with ephrin-and Eph receptor-expressing cells suggests that this might also be true for other cell types (Böhme et al., 1996; Holash et al., 1997) . It is important to note here that inhibitory as well as stimulatory signals can be associated with the same ephrin. The differences in the cellular response may therefore depend on the cell type or alterations in ligand clustering (Stein et al., 1998b ).
The precise cellular responses mediated by Eph receptor signaling during migration of cranial neural crest cells have yet to be determined. Smith et al. (1997) have suggested that Eph receptor signaling might mediate repulsion of cranial neural crest cells similar to the situation seen with trunk neural crest. This interpretation is based on complimentary expression of ephrin-B1 in the second arch and EphA4 and EphB1 in the third arch. The ligand ephrin-B2 would therefore act as a repulsive cue on EphA4 and EphB1 expressing neural crest cells, thus keeping the third arch neural crest cells within their correct territory. Interestingly, rhombomere transplantation experiments have shown that cranial neural crest cells maintain their original identity even though they enter those arches which happen to be adjacent to the transplantation site (Prince and Lumsden, 1994; Salvidar et al., 1996) . The tissues of the visceral arches appear therefore to be permissive for migration of cranial neural crest cells of different rhombomeric origin. These observations cannot be easily reconciled with a model of selective repulsion of neural crest cells originating from neighboring neural crest streams. A given ephrin gene is usually expressed in multiple visceral arches Bouillet et al., 1995; Flenniken et al., 1996) . Furthermore, we have provided evidence for co-expression of Eph receptors and their ligands in the mesoderm and neural crest of the visceral arches. Based on these observations, it is conceivable that Eph signaling during cranial neural crest migration may actually be attractive or adhesive.
What could be the biological roles of such attractive signals mediated by Eph receptors? In vivo lineage tracing studies of cranial neural crest cells in the chicken indicate that the cells tend to move in cohorts that stay in close contact with each other (Köntges and Lumsden, 1996) . Eph signaling in cranial neural crest cells could therefore be promoting formation of stable cell-cell contacts which may prevent cells from intermingling with cells of neighboring arches. Dominant negative versions of Eph receptors may therefore disrupt cell adhesion, and lead to blurring of the border between the adjacent neural crest streams by dispersing cells. At present, we are unable to distinguish whether Eph receptors mediate predominantly repulsive, attractive or both types of signals during cranial neural crest migration. Purification of cranial neural crest cells and the establishment of in vitro assays will be necessary to distinguish between these three possibilities for Eph signaling in cranial neural crest migration.
Experimental procedures
Embryo collection
Pigmented Xenopus laevis frogs were purchased from African Reptile Park (Tokai, South Africa), and albinos from Dr. Charles Thiébaud (Station de zoologie expérimentale, Université de Genève, Chêne-Bougeries, Switzerland). Xenopus embryos were obtained by in vitro fertilization as previously described (Newport and Kirschner, 1982; Brändli and Kirschner, 1995) and staged according to Nieuwkoop and Faber (1956) .
Screening of cDNA libraries
cDNAs encoding Xenopus EphA2 were isolated by screening a lZAPII Xenopus stages 28-30 head cDNA library (Hemmati-Brivanlou et al., 1991) kindly provided by Dr. Richard Harland. Partial cDNAs, G42 and G50 (Brändli and Kirschner, 1995) , which are derived from two pseudoallelic Xenopus EphA2 genes were used to generate 32 P-labeled probes by random-priming (Heller and Brändli, 1997) . Library screening was carried out with a mixture of both probes under conditions of high stringency using standard methods (Maniatis et al., 1989) . Thirteen positive clones were identified, purified and converted into Bluescript plasmids using the Rapid Excision Kit (Stratagene). Six plasmids were analyzed by restriction fragment mapping and DNA sequencing. One clone, HD.C2 (2 kb), was found to contain the G50 sequence. The other clones contained the G42 sequence. The longest cDNA clone, HD.C5 (4.6 kb), was sequenced on both strands by the double-strand dideoxy-chain termination method using T7 DNA polymerase (Sequenase Version 2.0; Amersham Life Sciences). Homology searches were performed using BLAST programs (Altschul et al., 1990) . Identification of the signal peptide and prediction of the cleavage site was carried out via WWW server at the Center for Biological Sequence Analysis (http://www.cbs.dtu.dk/services/SignalP/) using the SIGNALP method (Nielsen et al., 1997) . The nucleotide sequence of Xenopus EphA2 (clone HD.C5) is deposited at the EBI Nucleotide Database under the accession number AJ002493.
In situ hybridization in whole mount and on tissue sections
Whole mount in situ hybridization with digoxigeninlabeled antisense RNA probes was carried out essentially according to Harland (1991) . The standard protocol was modified by replacing methanol with ethanol and omitting the RNase digestion step. Antisense RNA probes were synthesized using either the digoxigenin-or fluorescein-RNA labeling mix (Boehringer Mannheim). Unincorporated nucleotides were removed by gel filtration through G-50 Sephadex columns (Quick Spin Columns, Boehringer Mannheim). Double in situ hybridizations with digoxigeninand fluorescein-labeled antisense RNA probes were carried out according to the standard protocol with the following modifications. Both probes were added simultaneously at 0.5-1 mg/ml each in hybridization buffer to the embryos. Sheep anti-digoxigenin Fab fragments conjugated to alkaline phosphatase (Boehringer Mannheim) were used to detect digoxigenin-labeled probes. The first color reaction would be for the least abundant transcript using the darkest chromogen. Thus, color development was performed using BM purple (Boehringer Mannheim) first. After the signal reached desired levels, the phosphatase activity was quenched by treating embryos with 100 mM Tris-HCl, pH 7.4; 150 mM NaCl; 10 mM EDTA for 10 min at 65°C, and subsequent dehydration in 100% ethanol for 10 min at room temperature. Samples were gradually rehydrated, re-blocked, and then the second antibody (sheep anti-fluorescein Fab fragments conjugated to alkaline phosphatase; Boehringer Mannheim) was added. The second color reaction was carried out using magenta phosphate (5-bromo-6-chloro-3-indolyl phosphate; Sigma B-5667) as a substrate. Magenta phosphate (25 mg/ml stock in dimethylformamid) was used at a concentration of 175 mg/ml in alkaline phosphatase buffer (Harland, 1991) . Embryos were cleared in Murray's clear (benzyl alcohol/ benzyl benzoate, 1:2). Photography, scanning and processing of slides have been described previously (Heller and Brändli, 1997) .
In situ hybridizations on embryonic sections was performed as follows. Fixation of embryos, embedding in agarose and sectioning at 50-100 mm with a vibrating blade microtome has been described previously (Heller and Brändli, 1997) . The sections were transferred to PBS-0.1% Tween and processed for in situ hybridization as described above. The protease digestion step was omitted.
Plasmids and constructs
Following plasmids were constructed for RNA probe synthesis. (a) plasmid BS-flEA2, containing the entire open reading frame (nucleotides 192-3125) of Xenopus EphA2, and (b) plasmid BS-cdEA2, containing sequences covering the cytoplasmic domain and the 3′ non-coding region (nucleotides 1985-3731) of Xenopus EphA2. The plasmids were generated using polymerase chain reaction (PCR)-based subcloning procedures. For pBS-flEA2, the PCR primers were designed with BamHI (sense) and XbaI (antisense) restriction sites. PCR primers for constructing pBS-cdEA2 were made with XbaI (sense) and BamHI (antisense) restriction sites. Amplification products were ligated into Bluescript II SK+ vectors (Stratagene).
A plasmid containing the entire Xenopus AP-2 cDNA (Winning et al., 1991) and plasmid Pag-B (Winning and Sargent, 1994) encoding Xenopus EphA4 (Pagliaccio) were kindly provided by Dr. Tom Sargent (National Institute of Health, Bethesda, MD, USA). Plasmid Bs.EP400 containing a fragment of the Xenopus Krox-20 lacking the zinc finger region (Bradley et al., 1992 ) was a gift of Dr. David Wilkinson (National Institute for Medical Research, London, UK). Plasmid SP73-XtwiT18 BAM/SphI′′T3A′′ (Hopwood et al., 1989 ) was used to synthesize Xenopus twist antisense transcripts (gift of Dr. John Gurdon, Wellcome/CRC Institute, Cambridge, UK).
For in vitro synthesis of RNA encoding Xenopus EphA2 derivatives, following plasmids were constructed by PCR (see also (nucleotides 192-802) . The sense primers contained either BglII (pCS-scEA2, pCS-FNIII(1)EA2, pCS-cysEA2, and pCS-globEA2) or BamHI (pCS-flEA2 and pCS-tmEA2) restriction sites. Antisense primers were designed with termination codons and restriction sites (StuI for pCS-flEA2 and pCS-tmEA2; BspEI for pCS-scEA2; and EcoRI for pCS-FNIII(1)EA2, pCS-cysEA2 and pCS-globEA2). Amplification products were generated using the Expand High Fidelity PCR system (Boehringer Mannheim) and subcloned into the CS2+ expression vector (Rupp et al., 1994; Turner and Weintraub, 1994) . Plasmids were verified by DNA sequencing. The CS2+ vector and plasmid CS2+ nbgal, CS2+ derivative permitting synthesis of RNA encoding a fusion protein of b-galactosidase with the SV40 large T nuclear localization signal, were kindly provided by Dr.
David Turner (University of Michigan, Ann Harbor, MI, USA).
The APtag-2 vector was used to construct plasmid EphA2-AP encoding a chimaeric protein consisting of the extracellular domain of Xenopus EphA2 fused to human placental alkaline phosphatase. The EphA2 cDNA sequence (nucleotides 192-1802) was amplified by PCR, the amplification product was digested with BglII and BspEI and inserted into the corresponding sites of the APtag-2 vector. Plasmid APtag-4 (H.-J. Cheng and J.G. Flanagan, unpublished data) encoding secreted human heat-stable alkaline phosphatase was used a negative control for in situ experiments. Both APtag plasmids were kindly provided by Dr. John Flanagan (Harvard Medical School, Boston, MA, USA).
Northern blot analysis
Total RNA was isolated from unfertilized eggs and embryos of various developmental stages using TRIzol reagent (GIBCO BRL) as described previously (Heller and Brändli, 1997) . Polyadenylated RNA was purified from total RNA preparation using the mRNA Purification Kit (Pharmacia Biotech). Polyadenylated RNA samples (equivalents from 75 eggs or embryos, respectively) were separated on a 1.2% agarose gel with 6% formaldehyde and capillary blotted onto a nylon membrane (Hybond-N, Amersham). Two separate probes were used for Northern blot hybridization. Probe 1 was a fragment encoding the entire open reading frame of Xenopus EphA2 (nucleotide 192-3125). Probe 2 was a HindIII-KpnI fragment (381 bp) of the ornithine decarboxylase cDNA isolated from plasmid ODC1 (Isaacs et al., 1992) kindly provided by Dr. Harry Isaacs (University of Bath, UK). The blot was hybridized in 50% formamide at 42°C with 32 P-labeled, randomly primed DNA probes. The blot was washed twice with 2× SSC at room temperature for 10 min each; and twice with 1× SSC, 1% SDS, at 55°C for 10 min each before exposure to X-ray films.
In vitro transcription and microinjections
In vitro synthesis of capped RNA from linearized plasmids was carried out using the MEGAscript SP6 kit (Ambion). The ratio of cap analog (diguanosine triphosphate, G(5′)ppp(5′)G; Pharmacia Biotech) to GTP was 4:1. Unincorporated nucleotides were removed by gel filtration through G-50 Sephadex columns (Quick Spin Columns, Boehringer Mannheim). The RNA concentration was determined spectrophotometrically. Embryos in 2% Ficoll, 1× MMR (Newport and Kirschner, 1982) were injected with RNA at the two-cell stage into one blastomere using a pneumatic PLI-100 injector (Medical Systems). Injected embryos were cultured at 16°C until the desired developmental stage was reached. Where indicated, embryos were coinjected with RNA encoding nuclear b-galactosidase (100 pg/blastomere) for lineage tracing.
b-Galactosidase staining
Embryos were fixed in MEMFA (Harland, 1991) for 30 min at room temperature, rinsed three times with PBS and stained at 37°C in PBS containing 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-bd-galactopyranoside), 2 mM MgCl 2 . Once staining reached the desired intensity, the embryos were refixed in MEMFA for 1 h at room temperature, rinsed with PBS and dehydrated in absolute ethanol. Stained embryos were stored at −20°C until they were used for in situ hybridization.
Production of AP fusion proteins and RAP in situ analysis
Plasmids APtag-4 and EA2-AP were transiently transfected by electroporation into COS cells (kindly provided by Dr. Ueli Suter, ETH Zürich) to produce soluble alkaline phosphatase and EphA2-alkaline phosphatase proteins, respectively. Cell culture, processing of cell supernatants and determination of alkaline phosphatase activity by a colorimetrical assay were carried out as described (Flanagan and Leder, 1990; Cheng et al., 1995) . The supernatants were concentrated six fold by centrifugation using BIOMAX-50K filter devices (Millipore). Concentrated supernatants were stored at 4°C with 20 mM HEPES, pH 7.4. The presence of recombinant alkaline phosphatase proteins in cell culture supernatants was determined by immunoprecipitation and Western blotting using a rabbit polyclonal antihuman alkaline phosphatase serum (DAKO, #A0268).
The RAP in situ analysis procedure (Cheng and Flanagan, 1994; Brennan et al., 1997) was adapted for the staining of Xenopus embryos. Xenopus embryos were fixed with 4% paraformaldehyde/PBS for 30 min, and washed three times with PBS/0.8% Triton X-100 for 5 min each. The embryos were incubated with the six-fold concentrated EphA2-AP supernatants containing 20 mM HEPES, pH 7.4 for 72 h at room temperature. Embryos were washed six times with Hanks' balanced salt solution (HBSS; Sigma H-6648) for 5 min each, and refixed in PBS with 4% paraformaldehyde for 20 min. Embryos were rinsed and incubated with HBSS at 65°C for 1 h to inactivate endogenous cellular phosphatases. The color reactions were performed by incubating the embryos with BM purple for 3-4 days at 4°C. The embryos were either sectioned or cleared in Murray's clear and photographed as described above.
